下一个

自动播放

Phase II trial show nilotinib achieves remission Philadelphia-positive acute lymphocytic leukaemia

7 意见 • 08/04/23
分享
嵌入
administrator
administrator
订户
0

At a press conference during the 2014 American Society of Hematology (ASH) Annual Meeting, Dr Oliver Ottmann (Goethe-University Hospital, Frankfurt, Germany) discusses a Trial of the European Working Group for Adult ALL (EWALL-PH-02), which evaluated nilotinib and chemotherapy for first-line treatment in elderly patients with de novo Philadelphia chromosome/BCR-ABL1-positive acute lymphoblastic leukaemia.

显示更多
0 注释 sort 排序方式
脸书评论

下一个

自动播放